Fig. 7. (A–C) Western blot data showing that the increased expression of CXCL13, CXCR5, and GAT-1 proteins after chronic constriction injury (CCI) surgery in the DRG, sciatic nerve, and plantar skin was reversed by botulinum toxin type A (BTX-A). CXCL13: chemokine ligand 13, CXCR5: C-X-C chemokine receptor type 5, GAT-1: GABA transporter 1, DRG: dorsal root ganglia. The error bar means mean ± standard deviation. aP < 0.05 vs. CCI + normal saline (NS) group, One-way ANOVA, n = 3 in each group.
© Korean J Pain
